Analyzing 77 studies involving 10,962 patients from 28 countries, this research found that 40.5 percent of patients receiving platinum-based chemotherapy drugs were affected by chronic peripheral nerve pain. The next highest group, at 38 percent, were those treated with a class of drugs known as taxanes. Overall, the highest rates of neuropathy were found in people treated for lung cancer, with 62 percent experiencing it.
The high toxicity of chemotherapy drugs is hardly a modern phenomenon. The first ones were derived from mustard gas, a chemical warfare agent used in the First World War. Introduced as cancer treatments from the 1940s onwards, the search for medical applications of mustard compounds continued through to the 1970s. Illustrating how little progress has since been made in the conventional treatment of cancer, chemical derivatives of mustard gas are still being used on patients today.
Disturbingly, therefore, research carried out in the UK has found that, in some hospitals, within 30 days of starting treatment, chemotherapy kills up to 50 per cent of patients who receive it. Unrealized even by many doctors, the overall contribution of chemotherapy to 5-year cancer survival in adults has been estimated to be a mere 2.3 percent in Australia and just 2.1 percent in the United States.
To check out Dr. Rath’s Cellular Health recommendations for cancer, see this page on our website.
Zinc May Support Infant Brain Development and Cognition
February 7, 2025Vaccine Rolled Out to Millions ‘Could Cause Neurological Illness’
February 7, 2025Cancer Drugs Cause Chronic Peripheral Nerve Pain in 40 Percent of Patients
News
Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the available evidence.
[Source: medicalxpress.com]
[Image source: Adobe Stock]
Comment
Analyzing 77 studies involving 10,962 patients from 28 countries, this research found that 40.5 percent of patients receiving platinum-based chemotherapy drugs were affected by chronic peripheral nerve pain. The next highest group, at 38 percent, were those treated with a class of drugs known as taxanes. Overall, the highest rates of neuropathy were found in people treated for lung cancer, with 62 percent experiencing it.
The high toxicity of chemotherapy drugs is hardly a modern phenomenon. The first ones were derived from mustard gas, a chemical warfare agent used in the First World War. Introduced as cancer treatments from the 1940s onwards, the search for medical applications of mustard compounds continued through to the 1970s. Illustrating how little progress has since been made in the conventional treatment of cancer, chemical derivatives of mustard gas are still being used on patients today.
Disturbingly, therefore, research carried out in the UK has found that, in some hospitals, within 30 days of starting treatment, chemotherapy kills up to 50 per cent of patients who receive it. Unrealized even by many doctors, the overall contribution of chemotherapy to 5-year cancer survival in adults has been estimated to be a mere 2.3 percent in Australia and just 2.1 percent in the United States.
To check out Dr. Rath’s Cellular Health recommendations for cancer, see this page on our website.
Dr. Rath Health Foundation
Related posts
Alarming Levels of Microplastics Discovered in Human Brain Tissue, Linked to Dementia
Read more